← Back to Patent Explorer
US4201778A Expired / Lapsed US ⏱️ 0.0 years remaining

6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1977-11-08
•
Granted: 1980-05-06
•
Expires: 1997-11-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 6-acyloxy-3,20-dioxo-1,4,6-pregnatrienes and 6-acyloxy-3,20-dioxo-4,6-pregnadienes, useful anti-inflammatory agents, are prepared by reaction of the corresponding 3,6,20-trioxo-1,4-pregnadiene or 3,6,20-trioxo-4-pregnene with an acyl halide or an acid anhydride in pyridine. Preferred anti-inflammatory agents are 6-alkanoyloxy-9 alpha -halogeno-16-methyl-1,4,6-pregnatriene-3,20-diones. Also described are novel 6-oxo-9 alpha -halogeno-16-substituted-1,4-pregnadienes, useful as intermediates in preparing the corresponding 6-acyloxy-1,4,6-pregnatrienes and which also exhibit anti-inflammatory activity per se.

Inventors

  • 👤 Richard W. Draper

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 21:45
CPC Classifications
C; C07; C07J; C07J5/00; C07J5/0046; C07J5/0061; C07J5/0069; C07J5/0076; A; A61; A61P; A61P17/00; A61P29/00; C07J31/00; C07J31/006; C07J7/00; C07J7/008; C07J7/0085; C07J71/00; C07J71/0005; C07J71/0026; C07J71/0031; C07J71/0036; C07J71/0057; C07J71/0068; C07J71/0073; C07J71/0089

Claims Analysis

Total Claims: 32
Claim 1
Independent Claim 349 words
A 6-acyloxy-3,20-dioxo-1,4,6-pregnatriene of the following formula I: ##STR13## wherein A is hydrogen or, provided Y is (H,βOH), A is chlorine, fluorine or methyl; B is hydrogen or, together with Q, is a 14α,17α-alkylidenedioxy derivative; X is hydrogen, fluorine or chlorine; Y is oxygen, (H,βOH), (H,βOCOH); or (H,β-chlorine) or (H,β-fluorine) provided X is chlorine; Z is hydrocarboncarbonyl, alkoxycarbonyl, thioalkoxycarbonyl, or thioalkoxythiocarbonyl wherein Z has up to 12 carbon atoms; Q is hydrogen provided W is (H, lower alkyl); or OV wherein V is hydrogen or an acyl radical of a hydrocarboncarboxylic acid having up to 12 carbon atoms or an acyl radical of benzoic acid substituted by a halogen or methoxy group or an acyl radical of retinoic acid provided W is other than (H,α-retinoyloxy); W is (H, lower alkyl); (H,α-OV 1 ) wherein V 1 is hydrogen or an acyl radical of an acid selected from the group consisting of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, and isonicotinic acid; ═CHT wherein T is hydrogen, lower alkyl, fluorine or chlorine, and W and Q taken together is a 16α,17α-lower alkylidenedioxy; a 16α,17α-cycloalkylidenedioxy; the grouping ##STR14## wherein R and R 1 are lower alkyl; or the grouping ##STR15## wherein R 2 is lower alkyl or phenyl; M is --OR 3 when Q is O-acyl, R 3 being lower alkyl or halogeno lower alkyl; --CHO, acetals, hemiacetals and acylals thereof; --COOR 4 wherein R 4 is alkyl having up to 12 carbon atoms; --CH 2 G wherein G is halogen having an atomic weight of less than 100 provided Q is not hydrogen, or G is OV 2 wherein V 2 is hydrogen, an acyl radical of an acid selected from the group consisting of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, isonicotinic acid, or phosphoric acid and mono- and dialkali and alkaline earth metal salts thereof; and G together with Q is an alkylidenedioxy or an alkylorthoalkanoate; and the 1,2-dihydro analogs of the foregoing.
Claim 2
Dependent Claim 349 words
A 6-acyloxy-3,20-dioxo-1,4,6-pregnatriene of the following formula I: ##STR13## wherein A is hydrogen or, provided Y is (H,βOH), A is chlorine, fluorine or methyl; B is hydrogen or, together with Q, is a 14α,17α-alkylidenedioxy derivative; X is hydrogen, fluorine or chlorine; Y is oxygen, (H,βOH), (H,βOCOH); or (H,β-chlorine) or (H,β-fluorine) provided X is chlorine; Z is hydrocarboncarbonyl, alkoxycarbonyl, thioalkoxycarbonyl, or thioalkoxythiocarbonyl wherein Z has up to 12 carbon atoms; Q is hydrogen provided W is (H, lower alkyl); or OV wherein V is hydrogen or an acyl radical of a hydrocarboncarboxylic acid having up to 12 carbon atoms or an acyl radical of benzoic acid substituted by a halogen or methoxy group or an acyl radical of retinoic acid provided W is other than (H,α-retinoyloxy); W is (H, lower alkyl); (H,α-OV 1 ) wherein V 1 is hydrogen or an acyl radical of an acid selected from the group consisting of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, and isonicotinic acid; ═CHT wherein T is hydrogen, lower alkyl, fluorine or chlorine, and W and Q taken together is a 16α,17α-lower alkylidenedioxy; a 16α,17α-cycloalkylidenedioxy; the grouping ##STR14## wherein R and R 1 are lower alkyl; or the grouping ##STR15## wherein R 2 is lower alkyl or phenyl; M is --OR 3 when Q is O-acyl, R 3 being lower alkyl or halogeno lower alkyl; --CHO, acetals, hemiacetals and acylals thereof; --COOR 4 wherein R 4 is alkyl having up to 12 carbon atoms; --CH 2 G wherein G is halogen having an atomic weight of less than 100 provided Q is not hydrogen, or G is OV 2 wherein V 2 is hydrogen, an acyl radical of an acid selected from the group consisting of a hydrocarboncarboxylic acid having up to 12 carbon atoms, benzoic acid substituted by a halogen or methoxy group, retinoic acid, isonicotinic acid, or phosphoric acid and mono- and dialkali and alkaline earth metal salts thereof; and G together with Q is an alkylidenedioxy or an alkylorthoalkanoate; and the 1,2-dihydro analogs of the foregoing.
Claim 3
Dependent Claim 17 words
A compound of claim 1, formula I, wherein X is fluorine or chlorine and Y is (H,βOH).
Claim 4
Dependent Claim 32 words
A compound of claim 1, formula I, wherein M is CH 2 OV 2 ; Q is OV; A, B are hydrogen; X is fluorine or chlorine; and Y is (H,62 OH).
Claim 5
Dependent Claim 44 words
A compound of claim 3 wherein X is fluorine and W is (H,CH 3 ), said compound having the following formula: ##STR16## wherein V and V 2 are each hydrogen or an acyl radical of a hydrocarboncarboxylic acid having up to 12 carbon atoms.
Claim 6
Dependent Claim 21 words
A 16β-methyl-1,4,6-pregnatriene of claim 4 wherein V is an acyl radical of a hydrocarboncarboxylic acid having up to 8 carbon atoms.
Claim 7
Dependent Claim 38 words
A compound of claim 5 wherein each of V and V 2 is an acyl radical of a lower alkanoic acid having two to four carbon atoms and Z is a hydrocarboncarbonyl having up to eight carbon atoms.
Claim 8
Dependent Claim 9 words
A compound of claim 6 which is 9α-fluoro-16β-methyl-1,4,6-pregnatriene-6,11β,17α,21-tetrol-3,20-dione 6,17,21-tripropionate.
Claim 9
Dependent Claim 10 words
A compound of claim 6 which is 9α-fluoro-16β-methyl-1,4,6-pregnatriene-6,11β,17α,21-tetrol-3,20-dione 6,21-dipropionate 17-isobutyrate.
Claim 10
Dependent Claim 10 words
A compound of claim 3 which is 9α-chloro-16β-methyl-1,4,6-pregnatriene-6,11β,17α,21-tetrol-3,20-dione 6-acetate 17,21-dipropionate.
Claim 11
Dependent Claim 10 words
A compound of claim 2 which is 9α-fluoro-16α,17α-isopropylidenedioxy-1,4,6-pregnatriene-[6,21-diol] 6,11β,21-triol-3,20-dione 6,21-diacetate.
Claim 12
Dependent Claim 9 words
A compound of claim 4 which is 9α-fluoro-16α-methyl-1,4,6-pregnatriene-6,11β,17α,21-tetrol-3,20-dione 6,17,21-tripropionate.
Claim 13
Dependent Claim 43 words
The method of treating an inflammatory condition in a warm-blooded animal which comprises administering to said animal a non-toxic, anti-inflammatory effective amount of a 6-acyloxy-3,20-dioxo-1,4,6-pregnatriene of formula I, claim 1, or of a 1,2-dihydro analog thereof; together with a non-toxic, pharmaceutically acceptable carrier.
Claim 14
Dependent Claim 23 words
The method of claim 12 which comprises topically administering to said animal a non-toxic, anti-inflammatory effective amount of a 6-acyloxy-16β-methyl-3,20-dioxo-1,4,6-pregnatriene of claim 5.
Claim 15
Dependent Claim 31 words
A pharmaceutical composition for use in the treatment of inflammation which comprises a 6-acyloxy-3,20-dioxo-1,4,6-pregnatriene of formula I, claim 1, or a 1,2-dihydro analog thereof; together with a non-toxic, pharmaceutically acceptable carrier.
Claim 16
Dependent Claim 123 words
A 3,6,20-trioxo-1,4-pregnadiene of the following formula: ##STR17## wherein X is hydrogen, fluorine, or chlorine; Y is (H,βOH), or (H,β-chlorine) provided X is chlorine; Q is hydroxy or OV wherein V is an acyl radical of a hydrocarboncarboxylic acid having up to 8 carbon atoms; V 2 is hydrogen or an acyl radical of a hydrocarboncarboxylic acid having up to 8 carbon atoms; and OV 2 together with Q is an alkylidenedioxy or an alkylorthoalkanoate; W is (H,CH 3 ), methylene, (H,αOV 2 ) wherein V 2 is as hereinabove defined; or together, W and Q form an alkylidenedioxy group or the grouping ##STR18## wherein R and R 1 are lower alkyl; or the grouping ##STR19## wherein R 2 is lower alkyl or phenyl.
Claim 17
Dependent Claim 123 words
A 3,6,20-trioxo-1,4-pregnadiene of the following formula: ##STR17## wherein X is hydrogen, fluorine, or chlorine; Y is (H,βOH), or (H,β-chlorine) provided X is chlorine; Q is hydroxy or OV wherein V is an acyl radical of a hydrocarboncarboxylic acid having up to 8 carbon atoms; V 2 is hydrogen or an acyl radical of a hydrocarboncarboxylic acid having up to 8 carbon atoms; and OV 2 together with Q is an alkylidenedioxy or an alkylorthoalkanoate; W is (H,CH 3 ), methylene, (H,αOV 2 ) wherein V 2 is as hereinabove defined; or together, W and Q form an alkylidenedioxy group or the grouping ##STR18## wherein R and R 1 are lower alkyl; or the grouping ##STR19## wherein R 2 is lower alkyl or phenyl.
Claim 18
Dependent Claim 38 words
A compound of claim 15 wherein X is fluorine, Y is (H,βOH), W is (H,CH 3 ); and Q is OV, said compound having the formula: ##STR20## wherein V and V 2 are as defined in claim 15.
Claim 19
Dependent Claim 14 words
A compound of claim 16 wherein V is isobutyryl and V 2 is hydrogen.
Claim 20
Dependent Claim 16 words
A 16β-methyl compound of claim 16 wherein V is hydrocarboncarbonyl having up to 8 carbon atoms.
Claim 21
Dependent Claim 9 words
A compound of claim 18 which is 9α-fluoro-16β-methyl-1,4-pregnadiene-11β,17α,21-triol-3,6,20-trione 17,21-dipropionate.
Claim 22
Dependent Claim 9 words
A compound of claim 18 which is 9α-fluoro-16β-methyl-1,4-pregnadiene-11β,17α,21-triol-3,6,20-trione 17-valerate.
Claim 23
Dependent Claim 9 words
A compound of claim 15 which is 9α-fluoro-16α,17α-isopropylidenedioxy-1,4-pregnadiene-11β,21-diol-3,6,20-trione 21-acetate.
Claim 24
Dependent Claim 16 words
A pharmaceutical composition comprising a 3,6,20-trioxo-1,4-pregnadiene of claim 15 together with a non-toxic, pharmaceutically acceptable carrier.
Claim 25
Dependent Claim 35 words
The method of treating an inflammatory condition in a warm-blooded animal which comprises administering to said animal a non-toxic, anti-inflammatory active amount of a 3,6,20-trioxo-1,4-pregnadiene of claim 15, together with a non-toxic, pharmaceutically acceptable carrier.
Claim 26
Dependent Claim 23 words
The method of claim 23 which comprises topically administering to said animal a non-toxic, anti-inflammatory effective amount of a 3,6,20-trioxo-1,4-pregnadiene of claim 18.
Claim 27
Dependent Claim 81 words
The process for the preparation of a 3-oxo-6-acyloxy-1,4,6-pregnatriene of formula I, claim 1, or the 1,2-dihydro analog thereof wherein said acyl is an acid radical of an acid selected from the group consisting of a hydrocarboncarboxylic acid, an alkylcarbonic acid, an alkylthiocarbonic acid, and an alkyldithiocarbonic acid, said acid radical having up to 12 carbon atoms, which comprises the reaction of the corresponding 3,6-dioxo-6,7-dihydro-1,4-pregnadiene or 3,6-dioxo-6,7-dihydro-4-pregnene with an acid anhydride or an acid halide of said acid in a tertiary amine.
Claim 28
Dependent Claim 11 words
The process of claim 25 wherein said tertiary amine is pyridine.
Claim 29
Dependent Claim 41 words
The process of claim 25 wherein said tertiary amine is pyridine and wherein said 3,6-dioxo-1,4-pregnadiene reacts with an acid anhydride or an acid chloride of a lower alkanoic acid having up to 3 carbon atoms whereby is formed a 6-lower alkanoyloxy-1,4,6-pregnatriene.
Claim 30
Dependent Claim 41 words
The process of claim 25 wherein said tertiary amine is pyridine and wherein said 3,6-dioxo-1,4-pregnadiene reacts with an acid halide selected from the group consisting of benzoyl chloride, ethylchlorothiolformate, ethylchloroformate, whereby is formed a 6-benzoyloxy-1,4,6-pregnatriene, a 6-thioethoxycarbonyl-1,4,6-pregnatriene and a 6-ethoxycarbonyl-1,4,6-pregnatriene, respectively.
Claim 31
Dependent Claim 10 words
A compound of claim 3 which is 9α-fluoro-16β-methyl-1,4,6-pregnatriene-6,11β,17α,21-tetrol-3,20-dione 6-ethylcarbonate 17,21-dipropionate.
Claim 32
Dependent Claim 10 words
A compound of claim 3 which is 9α-fluoro-16β-methyl-1,4,6-pregnatriene-6,11β,17α,21-tetrol-3,20-dione 6-thioethyl-carbonate 21-acetate.

References Cited (Backward Citations)

US3079301A Cited
US2816902A Cited
US2937975A Cited
US2887499A Cited
US3032565A Cited
US3071580A Cited
US3131181A Cited
US3629303A Cited
US4024131A Cited
US4076708A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-05-06 1983-11-05 1984-05-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-05-06 1987-11-05 1988-05-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-05-06 1991-11-05 1992-05-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag